Screener/Healthcare/Medical - Diagnostics & Research

CRL

Charles River Laboratories International, Inc.NYSE
$160.06+2.06 (+1.30%)
S&P 500Mid CapHealthcareHigh Beta
$91.86
$228.39
$153.63
$161.16
EPS (TTM)$-2.90
P/E Ratio—
Dividend Yield—
Market Cap$7.53B
Volume311K
Prev Close$158.00
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q4 '25$994.2M-$276.3M$-5.5631.0%-27.8%
Q3 '25$1.0B$55.6M$1.1033.7%5.5%
Q2 '25$1.0B$52.7M$1.0634.6%5.1%
Q1 '25$984.2M$25.9M$0.5032.3%2.6%
Q4 '24$1.0B-$213.7M$-4.1728.4%-21.3%
Q3 '24$1.0B$70.3M$1.3334.6%7.0%
Q2 '24$1.0B$94.3M$1.7434.5%9.2%
Q1 '24$1.0B$74.5M$1.3034.1%7.4%
Get Your Daily Market Recap